Use of Bayesian statistics in drug development: Advantages and challenges.

about

Trends in epidemiology in the 21st century: time to adopt Bayesian methods.Integration of PKPD relationships into benefit-risk analysis Ultrathin strut biodegradable-polymer sirolimus-eluting stents: being wary or going with the flow?

P2860

Q30363272-858D0F82-78B9-4F03-A291-6CD17E20D93C Q30671571-D1C685AF-D4EF-4344-959E-521F7954FD73 Q55416982-5FDD2DD0-0C1B-4362-975A-E109D0C3168D

P2860

Use of Bayesian statistics in drug development: Advantages and challenges.

Item

http://www.wikidata.org/entity/Q40828042

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Use of Bayesian statistics in drug development: Advantages and challenges.

@en

type

Item

label

Use of Bayesian statistics in drug development: Advantages and challenges.

@en

prefLabel

Use of Bayesian statistics in drug development: Advantages and challenges.

@en

P1476

Use of Bayesian statistics in drug development: Advantages and challenges.

@en

P2093

Sandeep K Gupta

http://www.w3.org/2001/XMLSchema#string

P2860

Sifting the evidence-what's wrong with significance tests?

Bayesian versus frequentist statistical inference for investigating a one-off cancer cluster reported to a health department.

Bayesian Model Checking for Multivariate Outcome Data.

Bayesian computation and model selection without likelihoods

Methods in health service research. An introduction to bayesian methods in health technology assessment

Structural and parameter uncertainty in Bayesian cost-effectiveness models.

Toward evidence-based medical statistics. 2: The Bayes factor.

Bayesian clinical trials at the University of Texas M. D. Anderson Cancer Center.

Bayesian methods in health technology assessment: a review.

Adaptive design clinical trials: Methodology, challenges and prospect

P304

3-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/2229-516X.96789

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23776799

http://www.w3.org/2001/XMLSchema#string

P921

Amar

P932

3657986

http://www.w3.org/2001/XMLSchema#string

Use of Bayesian statistics in drug development: Advantages and challenges.

about

P2860

P2860

Use of Bayesian statistics in drug development: Advantages and challenges.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932